Phenotypisation of Sleep Pattern in Hypertensive Patients With Non Dipper Pattern
INTO-DIP
PhenotypIsatioN of Sleep Pattern in hyperTensive Patients With blOod Pressure Non-DIPper Status
1 other identifier
observational
143
1 country
11
Brief Summary
High blood pressure is the most common modifiable risk factor for cardiovascular diseases (CV). The large interindividual variability in clinical expression of the disease and response to treatment, however, makes the management of the hypertensive patient complex.Therefore, identifying phenotypes of hypertensive patients associated with a specific CV outcome or who tend to respond/not respond to treatment is of paramount importance for improving CV prevention. It has been shown that the phenotype of hypertensive patient with poor control of nighttime blood pressure values, especially when associated with a "non-dipper" profile, was associated with an increased risk of developing CV and cerebrovascular complications. The non-dipper profile and nocturnal hypertension are caused by several factors including excessive salt intake and dysautonomia. However, they are also inevitably influenced by sleep duration and the presence of sleep disorders: obstructive sleep apnea (OSA), but also insomnia and periodic movements of the lower limbs,such as those frequently seen in restless legs syndrome, are among the the main determinants related to altered nighttime pressure pattern. However, such disturbances are not systematically assessed during the performance of monitoring 24h pressor and their impact in the outcome of the hypertensive patient is unknown. The primary objective of this study is to phenotype non-dipper patients with or without nocturnal hypertension to determine the prevalence of sleep disorders such as sleep apnea syndrome, insomnia, and restless legs syndrome (RLS) (OSA diagnosed considering AHI\>5 events/hour, insomnia and RLS according to ICSD 3 criteria) and correlate the presence of various sleep disorders with cardiac organ damage, vascular, and renal damage mediated by hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2023
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2023
CompletedFirst Submitted
Initial submission to the registry
March 4, 2024
CompletedFirst Posted
Study publicly available on registry
March 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 16, 2024
April 1, 2024
1.7 years
March 4, 2024
April 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of sleep disorders
Phenotype patients with non-dipper status with or without nocturnal hypertension in order to establish the prevalence of sleep disturbances such as sleep apnea syndrome, insomnia and restless legs syndrome
baseline
Study Arms (1)
Non-dipper pattern at 24-hour BP monitoring
Defined as a nocturnal decrease systolic and/or in diastolic BP values \<10% compared to the corresponding daytime values;
Interventions
patients will undergo a home sleep study to evaluate the presence of sleep disorders
Eligibility Criteria
Patients with non-dipper status with or without nocturnal hypertension
You may qualify if:
- \>18 years old;
- arterial hypertension defined as: a) office systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg AND either 24-hour ambulatory systolic BP ≥130 mmHg and/or diastolic BP ≥80 mmHg OR b) the presence of antihypertensive treatment;
- non-dipper pattern at 24-hour BP monitoring (confirmed on repeated ABPM including one performed within 3 months prior to enrolment and one after enrolment, both on the same antihypertensive treatment, if any), defined as a nocturnal decrease systolic and/or in diastolic BP values \<10% compared to the corresponding daytime values;
- signed written informed consent;
You may not qualify if:
- shift workers
- atrial fibrillation/flutter;
- pregnancy and lactation;
- terminal malignant disease, life expectancy \<6 months;
- limb amputation;
- dementia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
UOSD Ipertensione Arteriosa "A.M. Pirrelli" - AUOC Policlinico di Bari, University of Bari,
Bari, Italy, Bari, 70120, Italy
Azienda Sanitaria Locale della provincia di Brindisi
Brindisi, Italy, Brindisi, 72100, Italy
Medicina Interna 1, Ambulatorio Ipertensione e Malattie Metaboliche AOU "Maggiore della carità"- Novara
Novara, Italy, Novara, 28100, Italy
Padova 1- Clinica Medica 3 · Dipartimento di Medicina · Azienda Ospedaliera di Padova, Italy
Padua, Italy, Padova, 35128, Italy
Padova 2 - UOC Medicina d'urgenza, Centro Regionale Specializzato per l'ipertensione arteriosa OSA - Azienda ospedaliera Università di Padova, Italy
Padua, Italy, Padova, 35128, Italy
UO Cardiologia, UO Pneumologia, Presidio Ospedaliero Cittadella, Azienda ULSS 6 Euganea, Cittadella, Italy.
Cittadella, Italy, PD, 35013, Italy
Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia- S.O.S Centro per la Cura dell'Ipertensione Arteriosa- Medicina II Cardiovascolare
Reggio Emilia, Italy, RE, 42122, Italy
Azienda Provinciale per i Servizi Sanitari, Provincia Autonoma di Trento- UO Medicina interna - Rovereto
Rovereto, Italy, Trento, 38068, Italy
Azienda sanitaria universitaria Giuliano-Isontina (ASU-GI)- SC (UCO) Medicina Clinica
Trieste, Italy, Trieste, 34128, Italy
Department of Medicine, University of Verona, Verona, Italy
Verona, Italy, Verona, 37126, Italy
Istituto Auxologico Italiano IRCCS
Milan, MI, 20149, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gianfranco Parati, MD
Istituto Auxologico Italiano IRCCS
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2024
First Posted
March 12, 2024
Study Start
May 4, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
April 16, 2024
Record last verified: 2024-04